Key Factors to Design Quality Stability Program for Drug Product and API Kim Huynh-Ba PHARMALYTIK Pharmalytik© OVERVIEW • Stability role in the drug development process…

1. 2 emeMasters ISSBA 2010 Angers, the 3 dof February 2010 Quality by Design Statistics and Modelisation in Pharmaceutical Development Alain PoncinLFB Biotechnologies Process…

Slide 11 Why do people use LOCF? Or why not? Naitee Ting, Allison Brailey Pfizer Global R&D CT Chapter Mini Conference Slide 2 2 Outline Last Observation Carried Forward…

Slide 1Current and planned clinical research in DMD Newcastle Collaborative work Dr Michelle Eagle Research Practitioner Physiotherapist Newcastle Muscle Centre Slide 2 Where…

Slide 1STANDARD COURSE IN CLINICAL TRIAL PIENGTHONG NARAKORN May 23, 2008 Slide 2 OUTLINE: March 24, 2008  From R&D product to licensing  Study design & research…

Slide 1EU rare diseases registry for Niemann-Pick Disease type A, B and C Tarekegn Hiwot Consultant in Inherited Metabolic Disorders University Hospital of Birmingham Slide…

1.QSYMIA™LisaLuna Medical Primary Care2. www.qsymia.com 3. What is Qsymia?Qsymia= Phentermine + Topiramate extended-releasePhentermine, Sympathomimetic amine anorecticTopiramate…

1. Introduction • In the past most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. • But…

1. Challenges of Harnessing theInformatics Landscape to Promote Health Behavior Change David B. Abrams, PhDExecutive Director, The Schroeder Institute for Tobacco Research…

DF/HCCDANA-FARBER / HARVARD CANCER CENTERDF/HCCMemberInstitutions1 Massachusetts General Hospital (MGH), 2 Brigham and Womens Hospital (BWH), 3 Dana-Farber Cancer Center…